Clinical Trial

Zoster Eye Disease Study

Study Description

Zoster Eye Disease Study

This is a multi-center, randomized, double-masked, placebo-controlled clinical trial of suppressive valacyclovir for one year in immunocompetent study participants with an episode of dendriform epithelial keratitis, stromal keratitis, endothelial keratitis, and/or iritis due to Herpes Zoster Ophthalmicus (HZO) in the year prior to enrollment.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Drug - Masked Placebo

Oral Placebo

Drug - Masked Oral Valacyclovir

Oral Valacyclovir 1000 mg/day

Additional Information

Official Study Title

Long-term Suppressive Valacyclovir Treatment for Herpes Zoster Ophthalmicus

Clinical Trial ID

NCT03134196

ParticipAid ID

DbDKxa